SKI Market

A+| A| A-|

Indian Indices

Sensex

74,775.74 -1,092.06
( -1.44%)

Global Indices

Nasdaq

51,069.65 379.68
(0.75%)

Dow Jones

7,605.10 20.47
(0.27%)

Hang Seng

66,385.32 1,692.20
(2.62%)

Nikkei 225

10,420.12 -5.84
(-0.06%)

Forex

USD-INR

95.93 0.16
(0.16%)

EUR-INR

111.54 0.10
(0.09%)

GBP-INR

128.71 -0.01
(-0.01%)

JPY-INR

0.60 0.00
(0.17%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Aurobindo Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524804

INE406A01037

391.1437121

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AUROPHARMA

34.22

83106.9

EPS(TTM)

Face Value()

Div & Yield %

41.81

Back

artemis electicals & projects ltd

Amal consolidated net profit declines 69.65% in the December 2025 quarter

Jan 16,2026

Net profit of Amal declined 69.65% to Rs 5.02 crore in the quarter ended December 2025 as against Rs 16.54 crore during the previous quarter ended December 2024. Sales rose 36.69% to Rs 62.59 crore in the quarter ended December 2025 as against Rs 45.79 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	62.59	45.79	37
OPM %	12.93	44.57	-
PBDT	8.45	20.24	-58
PBT	6.13	17.95	-66
NP	5.02	16.54	-70

74,775.74 -1,092.06 ( -1.44%)

51,069.65 379.68 (0.75%)

7,605.10 20.47 (0.27%)

66,385.32 1,692.20 (2.62%)

10,420.12 -5.84 (-0.06%)

95.93 0.16 (0.16%)

111.54 0.10 (0.09%)

128.71 -0.01 (-0.01%)

0.60 0.00 (0.17%)